Inflammatory Breast Cancer

Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer. In this post, I will discuss our most recent understanding of this aggressive disease.

almost all women with IBC have lymph node involvement at the time of diagnosis.

Continue reading “Inflammatory Breast Cancer”

Adjuvant Capecitabine the CREAT-X trial

CREAT-X, Capcetabine for Residual Cancer as Adjuvant Therapy trial is the first of it’s kind to look into further adjuvant chemotherapy in patients who received neoadjuvant chemotherapy.

Capecitabine adjuvant therapy is beneficial in Her2-negative Breast cancer with residual disease following Neoadjuvant therapy.


Continue reading “Adjuvant Capecitabine the CREAT-X trial”

Breast Cancer Neoadjuvant Therapy Part 2/3

Neoadjuvant therapy was discussed in a prior post, in this post I will discuss the following items

  • Patient evaluation throughout neoadjuvant therapy.
  • Treatment modalities in neoadjuvant therapy.
  • Special patient subgroups.
  • Management of the axilla.

Continue reading “Breast Cancer Neoadjuvant Therapy Part 2/3”

Breast Cancer Neoadjuvant Therapy Part 1/3


Neoadjuvant therapy refers to the systemic treatment of breast cancer before definitive surgery, it is also called preoperative therapy. Neoadjuvant therapy was initially used for patients with the advanced inoperable disease, however, it is now proved to be beneficial in different subsets of patients including those with early-stage operable breast cancer.

Continue reading “Breast Cancer Neoadjuvant Therapy Part 1/3”